Dietary supplementation with L‐methylfolate, choline and betaine boosted one‐carbon metabolism, resulting in enhanced PP2A methylation and decreased Fyn and phospo‐Tau levels, which slowed cognitive decline in a mouse model of tauopathy. The gene discussed is MAPT; the disease is tauopathy.